Form 8-K - Current report:
SEC Accession No. 0001564590-21-016704
Filing Date
2021-03-30
Accepted
2021-03-30 17:04:27
Documents
3
Period of Report
2021-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tern-8k_20210330.htm 8-K 28638
2 EX-99.1 tern-ex991_6.htm EX-99.1 244701
3 GRAPHIC gkldzrvrqhqp000001.jpg GRAPHIC 2908
  Complete submission text file 0001564590-21-016704.txt   278644
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39926 | Film No.: 21787499
SIC: 2834 Pharmaceutical Preparations